management is as for a non-pregnant woman with schizophrenia with consideration of various provisos outlined below:
if a woman is taking an atypical antipsychotic consideration should be given to switching to a low-dose typical antipsychotic, such as haloperidol, chlorpromazine or trifluoperazine
women with schizophrenia who are breastfeeding
women receiving depot medication should be advised that their infants may show extrapyramidal symptoms several months after administration of the depot - these are usually self-limiting.
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.